ipriflavone has been researched along with quercetin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ribári, O; Sziklai, I | 1 |
| Aiello, FB; Caltagirone, S; Colasante, A; Maggiano, N; Musiani, P; Piantelli, M; Ranelletti, FO; Rinelli, A | 1 |
| Almadori, G; Cattani, P; Ferlini, C; Ferrandina, G; Lanza, P; Maggiano, N; Piantelli, M; Ranelletti, FO; Scambia, G | 1 |
3 other study(ies) available for ipriflavone and quercetin
| Article | Year |
|---|---|
Flavonoids alter bone-remodelling in auditory ossicle organ cultures.
Topics: Animals; Bone Resorption; Collagen; Culture Techniques; Dinoprostone; Flavonoids; Guinea Pigs; Isoflavones; Male; Otosclerosis; Procollagen N-Endopeptidase; Quercetin; Stapes | 1995 |
Interaction with type II estrogen binding sites and antiproliferative activity of tamoxifen and quercetin in human non-small-cell lung cancer.
Topics: Aged; Analgesics; Animals; Binding, Competitive; Carcinoma, Non-Small-Cell Lung; Cell Division; Cell Line; Cell Nucleus; Cytosol; DNA, Neoplasm; Estradiol; Female; Humans; Isoflavones; Kinetics; Lung Neoplasms; Male; Middle Aged; Quercetin; Rats; Receptors, Estrogen; Rutin; Tamoxifen; Tumor Cells, Cultured | 1997 |
Growth-inhibitory effect of tamoxifen and quercetin and presence of type II estrogen binding sites in human laryngeal cancer cell lines and primary laryngeal tumors.
Topics: Apoptosis; Cell Cycle; Cell Division; Cell Line; Dose-Response Relationship, Drug; Estradiol; Humans; Isoflavones; Kinetics; Laryngeal Neoplasms; Quercetin; Receptors, Estrogen; Tamoxifen; Time Factors; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1998 |